145 related articles for article (PubMed ID: 31467924)
1. Evaluation of Red Cell Distribution Width to Lymphocyte Ratio as Potential Biomarker for Detection of Colorectal Cancer.
Huang J; Zhao Y; Liao L; Liu S; Lu S; Wu C; Wei C; Xu S; Zhong H; Liu J; Guo Y; Zhang S; Gao F; Tang W
Biomed Res Int; 2019; 2019():9852782. PubMed ID: 31467924
[TBL] [Abstract][Full Text] [Related]
2. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
3. Clinical Usefulness and Prognostic Value of Red Cell Distribution Width in Colorectal Cancer.
Song Y; Huang Z; Kang Y; Lin Z; Lu P; Lin Q; Cai Z; Cao Y; Zhu X
Biomed Res Int; 2018; 2018():9858943. PubMed ID: 30643826
[TBL] [Abstract][Full Text] [Related]
4. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
[TBL] [Abstract][Full Text] [Related]
7. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer.
Zhu X; Cao Y; Lu P; Kang Y; Lin Z; Hao T; Song Y
Sci Rep; 2018 Aug; 8(1):11814. PubMed ID: 30087357
[TBL] [Abstract][Full Text] [Related]
9. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.
Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y
Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311
[TBL] [Abstract][Full Text] [Related]
10. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum IGFBP-3 in colorectal cancer.
Hou YL; Luo P; Ji GY; Chen H
J Clin Lab Anal; 2019 Jul; 33(6):e22912. PubMed ID: 31218761
[TBL] [Abstract][Full Text] [Related]
12. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
13. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
14. The association and diagnostic value of red blood cell distribution width in colorectal cancer.
Shi C; Xie M; Li L; Li K; Hu BL
Medicine (Baltimore); 2019 May; 98(19):e15560. PubMed ID: 31083220
[TBL] [Abstract][Full Text] [Related]
15. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
[TBL] [Abstract][Full Text] [Related]
16. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
17. Plasma heat shock protein 90-alpha have an advantage in diagnosis of colorectal cancer at early stage.
Kasanga M; Liu L; Xue L; Song X
Biomark Med; 2018 Aug; 12(8):881-890. PubMed ID: 29939072
[TBL] [Abstract][Full Text] [Related]
18. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the significance of expression of CEA mRNA and levels of CEA and its related proteins in colorectal cancer patients.
Wang W; Li Y; Zhang X; Jing J; Zhao X; Wang Y; Han C
J Surg Oncol; 2014 Apr; 109(5):440-4. PubMed ID: 24783267
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]